The U.S. has already invested billions in potential coronavirus vaccines. Here’s where the deals stand
PUBLISHED FRI, AUG 14 20206:30 AM EDTUPDATED 17 MIN AGONoah Higgins-Dunn
- So far, the federal government has struck deals with a handful of pharmaceutical giants that have topped roughly $10.79 billion as part of Operation Warp Speed.
- The operation aims to provide at least 300 million doses of a coronavirus vaccine by January 2021.
- Moderna, Johnson & Johnson, Pfizer and BioNTech, Sanofi and GlaxoSmithKline, Novavax and AstraZeneca have all received funding from the operation for their vaccines.